spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022

CPhI Worldwide



Over 25,000 online and 23,000 in person attendees at the world’s largest pharma trade exhibition.

CPhI Worldwide (9-11 November, 2021), which held its first in-person event since 2019, hosted the global pharma community at the Fiera Milano, Milan, welcoming exhibitors and attendees from 146 countries.



This year’s smart event was a combination of a three-day live exhibition, and a month-long online event featuring both the latest market insights through live and on demand content sessions and of course networking opportunities. The digital solutions and online partnering enabled attendees to target contacts for in-person meetings in advance as well as facilitating virtual networking for global audiences unable to travel.

Highlighting the industry’s positivity for the return of in-person networking – in spite of the travel restrictions still in place in many countries – over 65% of visitors were international with over 23,000 in-person attendees. CPhI Worldwide’s online figures were equally impressive, with a global audience of over 25,000 actively participating.

“It’s really important for the industry to meet in person again, although we've been in touch with our customers for the entire period, it makes a huge difference to see people in real life and to discuss their business’s needs,” Karin Gerbens, Communications Director for DFE Pharma.

The event is widely seen as a barometer of pharma industry strength. Confidence in industry growth and new partnering is high and there were 2,761 meetings at the event scheduled through the online platform alone. Host nation, Italy – home to the largest pharma industry in Europe[1] – provided a large number of attendees, with Federfarma Lombardia and Aschimfarma-Federchimica hosting a press conference for dozens of national and international media.

"We were surprised not just by the high volume of foot traffic but also the quality of leads that we got. Even compared to 2019 we secured more quality leads this year." Tony Martin, Director of Regional Marketing, Grace.

CPhI Worldwide featured 58 content sessions, 104 speakers and 1,169 exhibitors. Key content covered some of the biggest issues in the last year including mRNA technology, connectivity, sourcing and supply chain transparency, sustainability and innovative approaches to manufacturing.



Speaking about the enthusiasm for the return of in person events, Group Director, Adam Andersen, commented: “All across the show floor and in partnering meetings our attendees are reporting a tremendous amount of excitement and appreciation of the benefits of being able to sit down again with both current and future business partners. Throughout the event’s three days, we saw a collaborative environment, a desire to nurture deeper partnerships, with both exhibitors and visitors looking to maximise the value they get from being back at the world’s leading pharma event.”

CPhI Worldwide 2022 will take place at the Messe Frankfurt, Germany (1-3 November, 2022) with the entire supply chain represented from ingredients, machinery and bio to contract services finished dosage and packaging.

Andersen added, “it’s been a really positive event to return to after the last two years, and the industry is extremely strong, with new supply networks and partners in high demand. There is a sense of optimism, enthusiasm, and positivity around 2022 and our CPhI and Pharmapack events globally, from North America to Europe and Asia. The industry has acknowledged the vital role in-person and hybrid meetings play in building networks and supporting a global supply chain.”
phone +31 (0)20 708 1637
email cphicustomerservice@ubm.com
web www.cphi.com
email Delhi, India
 
Print this page
Send to a friend
   
spacer
News and Press Releases

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

LivaNova PLC, a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place December 6 - 9 in Charleston, S.C.
More info >>


White Papers

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

RSSL

The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement